228 related articles for article (PubMed ID: 31404286)
1. Targeting the
Ramachandran Nair L; Liu X
J Addict Res Ther; 2019; 10(2):. PubMed ID: 31404286
[TBL] [Abstract][Full Text] [Related]
2. Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats.
Liu X
Int J Neuropsychopharmacol; 2014 Jan; 17(1):105-16. PubMed ID: 23953129
[TBL] [Abstract][Full Text] [Related]
3. Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.
Brunzell DH; McIntosh JM; Papke RL
Ann N Y Acad Sci; 2014 Oct; 1327(1):27-45. PubMed ID: 24730978
[TBL] [Abstract][Full Text] [Related]
4. Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling.
Parikh V; Ji J; Decker MW; Sarter M
J Neurosci; 2010 Mar; 30(9):3518-30. PubMed ID: 20203212
[TBL] [Abstract][Full Text] [Related]
5. Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus.
Alkondon M; Pereira EF; Almeida LE; Randall WR; Albuquerque EX
Neuropharmacology; 2000 Oct; 39(13):2726-39. PubMed ID: 11044743
[TBL] [Abstract][Full Text] [Related]
6. The opioid antagonist naltrexone inhibits activity and alters expression of alpha7 and alpha4beta2 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs.
Almeida LE; Pereira EF; Alkondon M; Fawcett WP; Randall WR; Albuquerque EX
Neuropharmacology; 2000 Oct; 39(13):2740-55. PubMed ID: 11044744
[TBL] [Abstract][Full Text] [Related]
7. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
Rollema H; Hurst RS
Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
[TBL] [Abstract][Full Text] [Related]
8. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
[TBL] [Abstract][Full Text] [Related]
9. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
[TBL] [Abstract][Full Text] [Related]
10. Levo-tetrahydropalmatine inhibits α4β2 nicotinic receptor response to nicotine in cultured SH-EP1 cells.
Huang YB; Ma ZG; Zheng C; Ma XK; Taylor DH; Gao M; Lukas RJ; Wu J
Acta Pharmacol Sin; 2022 Apr; 43(4):889-896. PubMed ID: 34253876
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs.
Cippitelli A; Brunori G; Schoch J; Armishaw CJ; Wu J; Zaveri NT; Giulianotti MA; Welmaker GS; Toll L
Psychopharmacology (Berl); 2018 Jun; 235(6):1745-1757. PubMed ID: 29572652
[TBL] [Abstract][Full Text] [Related]
12. Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice.
Quik M; Campos C; Grady SR
Biochem Pharmacol; 2013 Oct; 86(8):1153-62. PubMed ID: 23831952
[TBL] [Abstract][Full Text] [Related]
13. Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP.
Matsuyama S; Matsumoto A
J Pharmacol Sci; 2003 Oct; 93(2):180-7. PubMed ID: 14578586
[TBL] [Abstract][Full Text] [Related]
14. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
[TBL] [Abstract][Full Text] [Related]
15. Brainstem cholinergic pathways diminish cardiovascular and neuroinflammatory actions of endotoxemia in rats: Role of NFκB/α7/α4β2AChRs signaling.
Sallam MY; El-Gowilly SM; Fouda MA; Abd-Alhaseeb MM; El-Mas MM
Neuropharmacology; 2019 Oct; 157():107683. PubMed ID: 31247270
[TBL] [Abstract][Full Text] [Related]
16. An electrophysiological characterization of naturally occurring tobacco alkaloids and their action on human α4β2 and α7 nicotinic acetylcholine receptors.
Alijevic O; McHugh D; Rufener L; Mazurov A; Hoeng J; Peitsch M
Phytochemistry; 2020 Feb; 170():112187. PubMed ID: 31865001
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus.
Xiao C; Miwa JM; Henderson BJ; Wang Y; Deshpande P; McKinney SL; Lester HA
J Neurosci; 2015 Mar; 35(9):3734-46. PubMed ID: 25740504
[TBL] [Abstract][Full Text] [Related]
18. Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro.
Koval L; Lykhmus O; Zhmak M; Khruschov A; Tsetlin V; Magrini E; Viola A; Chernyavsky A; Qian J; Grando S; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2011 Apr; 43(4):516-24. PubMed ID: 21146628
[TBL] [Abstract][Full Text] [Related]
19. Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.
Liu X
Psychopharmacology (Berl); 2013 Nov; 230(2):203-13. PubMed ID: 23712602
[TBL] [Abstract][Full Text] [Related]
20. Involvement of nicotinic acetylcholine receptors in behavioral abnormalities and psychological dependence in schizophrenia-like model mice.
Noda Y; Uchida M; Mouri A; Yamada S; Goto S; Kitagaki S; Mamiya T; Kushima I; Arioka Y; Ozaki N; Yoshimi A
Eur Neuropsychopharmacol; 2020 Dec; 41():92-105. PubMed ID: 33109433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
